Eagle Rock

🔑 Quick Answer

Peripheral nerve stimulation (PNS) offers significantly higher success rates (90-95%) compared to medications (40-60%) for neuropathy treatment, with fewer side effects and no risk of dependency. While medications like gabapentin and Lyrica provide short-term symptom relief, PNS addresses nerve dysfunction directly with long-lasting results. At Eagle Rock Neuropathy and Pain Center in Idaho Falls, patients who switch from medications to PNS report 70% average pain reduction within the first month, often eliminating or significantly reducing medication dependence. Medicare covers both treatments, but PNS provides superior long-term outcomes.

PNS vs Medications for Neuropathy: Evidence-Based Comparison

Head-to-Head Comparison

Factor PNS Therapy Medications
Success Rate 90-95% 40-60%
Side Effects Minimal (mild tingling) Common (drowsiness, dizziness, weight gain)
Dependency Risk None Possible with opioids
Long-term Effectiveness Sustained 5-10+ years Often diminishes over time
Medicare Coverage ✓ Covered ✓ Covered
Daily Routine Impact None (device works automatically) Multiple daily doses required

Common Neuropathy Medications Compared

Gabapentin (Neurontin)

Pros:

  • Widely available and affordable
  • Well-studied for neuropathy
  • Non-opioid option

Cons:

  • 40-50% success rate
  • Drowsiness, dizziness common
  • Requires dose escalation

Pregabalin (Lyrica)

Pros:

  • FDA-approved for diabetic neuropathy
  • Faster acting than gabapentin
  • 60% effectiveness rate

Cons:

  • Expensive (brand name)
  • Weight gain, edema
  • Cognitive side effects

Duloxetine (Cymbalta)

Pros:

  • Treats pain and depression
  • 50-55% success rate
  • Once-daily dosing

Cons:

  • Nausea, dry mouth
  • Withdrawal symptoms if stopped suddenly
  • Not suitable for liver disease

Why PNS Often Outperforms Medications

Ready to Move Beyond Medications?

Eagle Rock Neuropathy and Pain Center in Idaho Falls helps patients transition from ineffective medications to proven PNS therapy with 90-95% success rates.

Schedule Free Consultation